Use of Co-Amoxiclav temporarily suspended amidst reports on fatalities

Date:

Colombo (LNW): The use of Co-Amoxiclav, a class of antibiotics, has been temporarily suspended amidst reports on the death of a patient at the Colombo National Hospital, who was treated with the said antibiotic, announced Health Minister Keheliya Rambukwella.

Early reports claimed that a 50-year old person who had arrived from Warakapola to receive treatment at the Colombo National Hospital for a cut wound died upon being administered the antibiotic.

There were 21,000 vaccines in the relevant drug category, and 18,000 of them have been used so far, but the situation is reported only in relation to one vaccine amongst them, the Minister said.

An investigation is also underway through the expert committee appointed to probe into issues related to medicines, he added.

Share post:

spot_imgspot_img

Popular

More like this
Related

Sri Lanka Tourism’s Race against Time to Hit 2025 Goals

Sri Lanka’s tourism industry is celebrating a symbolic milestone,...

Browns Investments PLC Expands Maldives Footprint with $57.5m Deal

Browns Investments PLC, the leisure and investment arm inside...

JVP/NPP Backs Refinery Deal it once blocked: Ranwala Saga Haunts Credibility

Sri Lanka’s Sapugaskanda oil refinery, a project long strangled...

Sri Lanka’s Foreign Investment Target: Ambitions Outpace Reality

As Sri Lanka navigates its post-crisis recovery, foreign direct...